Duchenne Muscular Dystrophy Treatment Market Worldwide Industry Analysis By Size, Trends And Segments Forecast To 2028

The research report "Global Duchenne Muscular Dystrophy (DMD) Treatment Market: by drug class(Corticosteroids, Pain management drugs) by distribution channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography- Global/Region/Country Forecast to 2028." The global duchnne muscular dystrophy treatment market size was estimated at USD 3.8 Bn in 2021, growing a CAGR rate of 38.4% during the forthcoming years 2022-2028.

Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on "Global Duchenne Muscular Dystrophy (DMD) Treatment Market: by drug class(Corticosteroids, Pain management drugs) by distribution channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography- Global/Region/Country Forecast to 2028."

View Detailed Report Description Here - https://precisionbusinessinsights.com/market-reports/global-duchenne-muscular-dystrophy-treatment-market/

Growing awareness about Duchenne Muscular Dystrophy is fuelling the Market growth:
Duchenne muscular dystrophy is one of the nine kinds of muscular dystrophy. It is a genetic disorder characterized by progressive degeneration and weakness of muscle. The onset of symptoms will be from early childhood in the age of 3-5. It is caused because of the absence of dystrophin protein, which assists to keep muscle cells intact. No known cure is there for duchenne muscular dystrophy however the treatment is given to control the symptoms for maximizing the quality of life of the patient. A few products are there marketed to treat duchenne muscular dystrophy-like Emflaza, Translama and Exodus 51.

One of the leading factors anticipated to bolster the market growth is increasing prevalence of duchenne muscular dystrophy. According to the NHS assessment 100 are born with duchenne muscular dystrophy in the UK every year While 349 new cases were reported in 2010 in the U.S. as per to Centre for disease control. Moreover, growing consciousness regarding duchenne muscular dystrophy and increase in healthcare expenditure are the factors propelling the market growth. But, low treatment seeking rate due to the late diagnosis and rapid prognosis of the disorder are the factors hampering the duchenne muscular dystrophy market growth.

Europe accounted for major share in the Duchenne Musclar Dystrophy Treatment Market:
Based on the regional analysis, duchenne muscular dystrophy treatment market is categorized into five major regions such as North America, Latin America, Europe, Asia Pacific, Middle East and Africa. Europe market is the leading market in the global duchenne muscular dystrophy treatment market due to the numerous treatments for DMD which are approved and are under review in EU. For example, PTC Therapeutics has currently obtained orphan drug designation as well as conditional approval for its Translama, a gene therapy for treating DPD. North America witnessed a considerable place in DMD treatment market due to the high prevalence of DMD. Latin America and Asia Pacific like emerging markets are projected to have considerable growth rate due to the large patient pool, growing healthcare expenditure and consciousness of DMD and increase in the prevalence of DMD.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=17193

Competitive Analysis - Duchenne Musclar Dystrophy Treatment Market
A few major players operating in the duchenne muscular dystrophy treatment market, which include Bristol-Myers Squibb(U.S), FibroGen, Inc (U.S), ITALFARMACO S.p.A. (Italy), Catabasis Pharmaceuticals, Inc.(U.S), NS Pharma, Inc. (U.S), Marathon Pharmaceuticals, LLC (U.S) and ReveraGen BioPharma, Inc. (U.S).

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.